アミファンプリジンの世界市場2021-2026:ジェネリック、特許

LP Informationが発行した調査報告書(LPI21JL16408)
◆英語タイトル:Global Amifampridine Market Growth 2021-2026
◆商品コード:LPI21JL16408
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:162
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LP Information社の「アミファンプリジンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ジェネリック、特許など、用途別には、重症筋無力症、カリウムチャネル遮断薬などにセグメント区分してまとめました。アミファンプリジンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・アミファンプリジンの世界市場概要(サマリー)
・アミファンプリジンの企業別販売量・売上
・アミファンプリジンの企業別市場シェア
・アミファンプリジンの世界市場規模 2016年-2021年:種類別(ジェネリック、特許)
・アミファンプリジンの世界市場規模 2016年-2021年:用途別(重症筋無力症、カリウムチャネル遮断薬)
・アミファンプリジンの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・アミファンプリジンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・アミファンプリジンのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・アミファンプリジンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・アミファンプリジン市場の成長要因・課題・動向
・アミファンプリジンの世界市場予測 2021年-2026年
・アミファンプリジンの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・アミファンプリジンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・アミファンプリジンのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・アミファンプリジンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・アミファンプリジンの世界市場予測:種類別(ジェネリック、特許)
・アミファンプリジンの世界市場予測:用途別(重症筋無力症、カリウムチャネル遮断薬)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Amifampridine will have significant change from previous year. By the most conservative estimates of global Amifampridine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Amifampridine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Amifampridine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Generic
Patent

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Myasthenia Gravis
Potassium Channel Blocker

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Jacobus Pharmaceutical
Unichem
BioMarin Pharmaceutical
Wockhardt
Glenmark Pharmaceuticals
Norris Pharm
BLD Pharm
Biosynth AG
Innovapharm
Founder Pharma
BroadPharm
CSNpharm
Merck

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amifampridine Consumption 2016-2026
2.1.2 Amifampridine Consumption CAGR by Region
2.2 Amifampridine Segment by Type
2.2.1 Generic
2.2.2 Patent
2.3 Amifampridine Sales by Type
2.3.1 Global Amifampridine Sales Market Share by Type (2016-2021)
2.3.2 Global Amifampridine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Amifampridine Sale Price by Type (2016-2021)
2.4 Amifampridine Segment by Application
2.4.1 Myasthenia Gravis
2.4.2 Potassium Channel Blocker
2.5 Amifampridine Sales by Application
2.5.1 Global Amifampridine Sale Market Share by Application (2016-2021)
2.5.2 Global Amifampridine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Amifampridine Sale Price by Application (2016-2021)

3 Global Amifampridine by Company
3.1 Global Amifampridine Sales Market Share by Company
3.1.1 Global Amifampridine Sales by Company (2019-2021)
3.1.2 Global Amifampridine Sales Market Share by Company (2019-2021)
3.2 Global Amifampridine Revenue Market Share by Company
3.2.1 Global Amifampridine Revenue by Company (2019-2021)
3.2.2 Global Amifampridine Revenue Market Share by Company (2019-2021)
3.3 Global Amifampridine Sale Price by Company
3.4 Global Manufacturers Amifampridine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amifampridine Product Location Distribution
3.4.2 Players Amifampridine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Amifampridine by Region
4.1 Global Amifampridine by Region
4.1.1 Global Amifampridine Sales by Region
4.1.2 Global Amifampridine Revenue by Region
4.2 Americas Amifampridine Sales Growth
4.3 APAC Amifampridine Sales Growth
4.4 Europe Amifampridine Sales Growth
4.5 Middle East & Africa Amifampridine Sales Growth

5 Americas
5.1 Americas Amifampridine Sales by Country
5.1.1 Americas Amifampridine Sales by Country (2016-2021)
5.1.2 Americas Amifampridine Revenue by Country (2016-2021)
5.2 Americas Amifampridine Sales by Type
5.3 Americas Amifampridine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Amifampridine Sales by Region
6.1.1 APAC Amifampridine Sales by Region (2016-2021)
6.1.2 APAC Amifampridine Revenue by Region (2016-2021)
6.2 APAC Amifampridine Sales by Type
6.3 APAC Amifampridine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Amifampridine by Country
7.1.1 Europe Amifampridine Sales by Country (2016-2021)
7.1.2 Europe Amifampridine Revenue by Country (2016-2021)
7.2 Europe Amifampridine Sales by Type
7.3 Europe Amifampridine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Amifampridine by Country
8.1.1 Middle East & Africa Amifampridine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Amifampridine Revenue by Country (2016-2021)
8.2 Middle East & Africa Amifampridine Sales by Type
8.3 Middle East & Africa Amifampridine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Amifampridine Distributors
10.3 Amifampridine Customer

11 Global Amifampridine Market Forecast
11.1 Global Amifampridine Forecast by Region
11.1.1 Global Amifampridine Forecast by Regions (2021-2026)
11.2.2 Global Amifampridine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Amifampridine Forecast by Type
11.7 Global Amifampridine Forecast by Application

12 Key Players Analysis
12.1 Jacobus Pharmaceutical
12.1.1 Jacobus Pharmaceutical Jacobus Pharmaceutical Company Information
12.1.2 Jacobus Pharmaceutical Amifampridine Product Offered
12.1.3 Jacobus Pharmaceutical Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Jacobus Pharmaceutical Main Business Overview
12.1.5 Jacobus Pharmaceutical Latest Developments
12.2 Unichem
12.2.1 Unichem Company Information
12.2.2 Unichem Amifampridine Product Offered
12.2.3 Unichem Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Unichem Main Business Overview
12.2.5 Unichem Latest Developments
12.3 BioMarin Pharmaceutical
12.3.1 BioMarin Pharmaceutical Company Information
12.3.2 BioMarin Pharmaceutical Amifampridine Product Offered
12.3.3 BioMarin Pharmaceutical Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 BioMarin Pharmaceutical Main Business Overview
12.3.5 BioMarin Pharmaceutical Latest Developments
12.4 Wockhardt
12.4.1 Wockhardt Company Information
12.4.2 Wockhardt Amifampridine Product Offered
12.4.3 Wockhardt Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Wockhardt Main Business Overview
12.4.5 Wockhardt Latest Developments
12.5 Glenmark Pharmaceuticals
12.5.1 Glenmark Pharmaceuticals Company Information
12.5.2 Glenmark Pharmaceuticals Amifampridine Product Offered
12.5.3 Glenmark Pharmaceuticals Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Glenmark Pharmaceuticals Main Business Overview
12.5.5 Glenmark Pharmaceuticals Latest Developments
12.6 Norris Pharm
12.6.1 Norris Pharm Company Information
12.6.2 Norris Pharm Amifampridine Product Offered
12.6.3 Norris Pharm Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Norris Pharm Main Business Overview
12.6.5 Norris Pharm Latest Developments
12.7 BLD Pharm
12.7.1 BLD Pharm Company Information
12.7.2 BLD Pharm Amifampridine Product Offered
12.7.3 BLD Pharm Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 BLD Pharm Main Business Overview
12.7.5 BLD Pharm Latest Developments
12.8 Biosynth AG
12.8.1 Biosynth AG Company Information
12.8.2 Biosynth AG Amifampridine Product Offered
12.8.3 Biosynth AG Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Biosynth AG Main Business Overview
12.8.5 Biosynth AG Latest Developments
12.9 Innovapharm
12.9.1 Innovapharm Company Information
12.9.2 Innovapharm Amifampridine Product Offered
12.9.3 Innovapharm Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Innovapharm Main Business Overview
12.9.5 Innovapharm Latest Developments
12.10 Founder Pharma
12.10.1 Founder Pharma Company Information
12.10.2 Founder Pharma Amifampridine Product Offered
12.10.3 Founder Pharma Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Founder Pharma Main Business Overview
12.10.5 Founder Pharma Latest Developments
12.11 BroadPharm
12.11.1 BroadPharm Company Information
12.11.2 BroadPharm Amifampridine Product Offered
12.11.3 BroadPharm Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 BroadPharm Main Business Overview
12.11.5 BroadPharm Latest Developments
12.12 CSNpharm
12.12.1 CSNpharm Company Information
12.12.2 CSNpharm Amifampridine Product Offered
12.12.3 CSNpharm Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 CSNpharm Main Business Overview
12.12.5 CSNpharm Latest Developments
12.13 Merck
12.13.1 Merck Company Information
12.13.2 Merck Amifampridine Product Offered
12.13.3 Merck Amifampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Merck Main Business Overview
12.13.5 Merck Latest Developments

13 Research Findings and Conclusion

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ アミファンプリジンの世界市場2021-2026:ジェネリック、特許(Global Amifampridine Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。